• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

LEDIPASVIR Drug Record

  • Summary
  • Interactions
  • Claims
  • LEDIPASVIR chembl:CHEMBL2374220 Approved

    Alternate Names:

    LEDIPASVIR ACETONATE
    GS-5885
    LEDIPASVIR
    WHO 9796
    GS 5885
    GS5885
    chembl:CHEMBL2374220
    drugbank:09027
    rxcui:1591922
    chemidplus:1256388-51-8
    pubchem.compound:67505836

    Drug Info:

    (0 More Sources)

    Publications:

    O'Brien TR et al., 2017, Race or genetic makeup for hepatitis C virus treatment decisions?, Hepatology
    Akuta N et al., 2017, Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan., J Med Virol
    O'Brien TR et al., 2014, Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C., Open Forum Infect Dis
  • LEDIPASVIR   IFNL4

    Interaction Score: 11.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    28100007 27357737 25734178


    Sources:
    PharmGKB

  • LEDIPASVIR   IFNL3

    Interaction Score: 9.09

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Combination therapy Ledipasvir,Sofosbuvir

    PMIDs:
    28100007 27357737 25734178


    Sources:
    PharmGKB FDA

  • PharmGKB: ledipasvir

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Akuta N et al., 2017, Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan., J Med Virol
    O'Brien TR et al., 2017, Race or genetic makeup for hepatitis C virus treatment decisions?, Hepatology
    O'Brien TR et al., 2014, Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C., Open Forum Infect Dis

  • TTD: GS-5885

    • Version: 2020.06.01

    Alternate Names:
    D06LUZ TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2374220

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • FDA: Ledipasvir

    • Version: 04-September-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21